| Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia W Salzer, B Bostrom, Y Messinger, AJ Perissinotti, B Marini Leukemia & Lymphoma 59 (8), 1797-1806, 2018 | 132 | 2018 |
| Role of T cell TGFβ signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection SM Faust, G Lu, BL Marini, W Zou, D Gordon, Y Iwakura, Y Laouar, ... The Journal of Immunology 183 (11), 7297-7306, 2009 | 83 | 2009 |
| Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations Z Miklja, A Pasternak, S Stallard, T Nicolaides, C Kline-Nunnally, B Cole, ... Neuro-oncology 21 (8), 968-980, 2019 | 79 | 2019 |
| Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma Z Miklja, VN Yadav, RT Cartaxo, R Siada, CC Thomas, JR Cummings, ... The Journal of clinical investigation 130 (10), 5313-5325, 2020 | 70 | 2020 |
| Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma C Koschmann, D Zamler, A MacKay, D Robinson, YM Wu, R Doherty, ... Oncotarget 7 (40), 65696, 2016 | 69 | 2016 |
| Common Sense Oncology: outcomes that matter CM Booth, M Sengar, A Goodman, B Wilson, A Aggarwal, S Berry, ... The Lancet Oncology 24 (8), 833-835, 2023 | 59 | 2023 |
| Targeting and therapeutic monitoring of H3K27M-mutant glioma K Wierzbicki, K Ravi, A Franson, A Bruzek, E Cantor, M Harris, MJ Homan, ... Current oncology reports 22, 1-9, 2020 | 58 | 2020 |
| The leukemia strikes back: a review of pathogenesis and treatment of secondary AML E Cheung, AJ Perissinotti, DL Bixby, PW Burke, KM Pettit, LL Benitez, ... Annals of hematology 98, 541-559, 2019 | 56 | 2019 |
| The effects of an informational video on patient knowledge, satisfaction and compliance with venous thromboembolism prophylaxis: a pilot study BL Marini, K Funk, MD Kraft, JM Fong, R Naanos, SM Stout, D Wagner Patient education and counseling 96 (2), 264-267, 2014 | 54 | 2014 |
| Catalyzing improvements in ALL therapy with asparaginase BL Marini, AJ Perissinotti, DL Bixby, J Brown, PW Burke Blood Reviews 31 (5), 328-338, 2017 | 52 | 2017 |
| Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia TM Weis, BL Marini, DL Bixby, AJ Perissinotti Critical reviews in oncology/hematology 141, 125-138, 2019 | 48 | 2019 |
| Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients AM Huang, BL Marini, D Frame, DM Aronoff, JL Nagel Transplant Infectious Disease 16 (5), 744-750, 2014 | 45 | 2014 |
| Risk factors for subtherapeutic levels of posaconazole tablet LA Tang, BL Marini, L Benitez, JL Nagel, M Miceli, C Berglund, ... Journal of Antimicrobial Chemotherapy 72 (10), 2902-2905, 2017 | 43 | 2017 |
| Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients BL Marini, SW Choi, CA Byersdorfer, S Cronin, DG Frame Biology of Blood and Marrow Transplantation 21 (5), 809-820, 2015 | 38 | 2015 |
| Risk factors and impact of Clostridium difficile recurrence on haematology patients GB Scappaticci, AJ Perissinotti, JL Nagel, DL Bixby, BL Marini Journal of Antimicrobial Chemotherapy 72 (5), 1488-1495, 2017 | 34 | 2017 |
| A single-center multidisciplinary approach to managing the global Erwinia asparaginase shortage BL Marini, J Brown, L Benitez, E Walling, RJ Hutchinson, R Mody, ... Leukemia & Lymphoma 60 (12), 2854-2868, 2019 | 31 | 2019 |
| Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes ES Herc, CA Kauffman, BL Marini, AJ Perissinotti, MH Miceli Leukemia & Lymphoma 58 (12), 2852-2858, 2017 | 31 | 2017 |
| Panobinostat penetrates the blood–brain barrier and achieves effective brain concentrations in a murine model MJ Homan, A Franson, K Ravi, H Roberts, MP Pai, C Liu, M He, ... Cancer chemotherapy and pharmacology 88, 555-562, 2021 | 26 | 2021 |
| The FOSSIL Study: FLAG or standard 7+ 3 induction therapy in secondary acute myeloid leukemia V Vulaj, AJ Perissinotti, JR Uebel, VR Nachar, GB Scappaticci, A Crouch, ... Leukemia research 70, 91-96, 2018 | 26 | 2018 |
| Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival G Chappell, M Geer, E Gatza, T Braun, T Churay, J Brisson, D Bixby, ... Bone Marrow Transplantation 54 (9), 1518-1520, 2019 | 24 | 2019 |